[1]
|
NUCLEOTIDE SEQUENCE [MRNA].
PubMed=7606716 [NCBI, ExPASy, EBI, Israel, Japan]
Stone S.,
Jiang P.,
Dayananth P.,
Tavtigian S.V.,
Katcher H.,
Parry D.,
Peters G.,
Kamb A.;
"Complex structure and regulation of the P16 (MTS1) locus.";
Cancer Res. 55:2988-2994(1995).
|
[2]
|
NUCLEOTIDE SEQUENCE [MRNA].
Linnenbach A.J.;
"mRNA isoform with alternate first exon-encoded sequences at the cyclin-dependent kinase inhibitor 2 (p16INK4/MTS1) locus and mapping analysis of the region by using long-PCR.";
Submitted (OCT-1995) to the EMBL/GenBank/DDBJ databases.
|
[3]
|
NUCLEOTIDE SEQUENCE [GENOMIC DNA].
Rieder M.J.,
Livingston R.J.,
Daniels M.R.,
Montoya M.A.,
Chung M.-W.,
Miyamoto K.E.,
Nguyen C.P.,
Nguyen D.A.,
Poel C.L.,
Robertson P.D.,
Schackwitz W.S.,
Sherwood J.K.,
Witrak L.A.,
Nickerson D.A.;
"NIEHS-SNPs, environmental genome project, NIEHS ES15478, Department of Genome Sciences, Seattle, WA (URL: http://egp.gs.washington.edu).";
Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
|
[4]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
DOI=10.1038/nature02465; PubMed=15164053 [NCBI, ExPASy, EBI, Israel, Japan]
Humphray S.J.,
Oliver K.,
Hunt A.R.,
Plumb R.W.,
Loveland J.E.,
Howe K.L.,
Andrews T.D.,
Searle S.,
Hunt S.E.,
Scott C.E.,
Jones M.C.,
Ainscough R.,
Almeida J.P.,
Ambrose K.D.,
Ashwell R.I.S.,
Babbage A.K.,
Babbage S.,
Bagguley C.L.,
Bailey J., ![]()
Banerjee R.,
Barker D.J.,
Barlow K.F.,
Bates K.,
Beasley H.,
Beasley O.,
Bird C.P.,
Bray-Allen S.,
Brown A.J.,
Brown J.Y.,
Burford D.,
Burrill W.,
Burton J.,
Carder C.,
Carter N.P.,
Chapman J.C.,
Chen Y.,
Clarke G.,
Clark S.Y.,
Clee C.M.,
Clegg S.,
Collier R.E.,
Corby N.,
Crosier M.,
Cummings A.T.,
Davies J.,
Dhami P.,
Dunn M.,
Dutta I.,
Dyer L.W.,
Earthrowl M.E.,
Faulkner L.,
Fleming C.J.,
Frankish A.,
Frankland J.A.,
French L.,
Fricker D.G.,
Garner P.,
Garnett J.,
Ghori J.,
Gilbert J.G.R.,
Glison C.,
Grafham D.V.,
Gribble S.,
Griffiths C.,
Griffiths-Jones S.,
Grocock R.,
Guy J.,
Hall R.E.,
Hammond S.,
Harley J.L.,
Harrison E.S.I.,
Hart E.A.,
Heath P.D.,
Henderson C.D.,
Hopkins B.L.,
Howard P.J.,
Howden P.J.,
Huckle E.,
Johnson C.,
Johnson D.,
Joy A.A.,
Kay M.,
Keenan S.,
Kershaw J.K.,
Kimberley A.M.,
King A.,
Knights A.,
Laird G.K.,
Langford C.,
Lawlor S.,
Leongamornlert D.A.,
Leversha M.,
Lloyd C.,
Lloyd D.M.,
Lovell J.,
Martin S.,
Mashreghi-Mohammadi M.,
Matthews L.,
McLaren S.,
McLay K.E.,
McMurray A.,
Milne S.,
Nickerson T.,
Nisbett J.,
Nordsiek G.,
Pearce A.V.,
Peck A.I.,
Porter K.M.,
Pandian R.,
Pelan S.,
Phillimore B.,
Povey S.,
Ramsey Y.,
Rand V.,
Scharfe M.,
Sehra H.K.,
Shownkeen R.,
Sims S.K.,
Skuce C.D.,
Smith M.,
Steward C.A.,
Swarbreck D.,
Sycamore N.,
Tester J.,
Thorpe A.,
Tracey A.,
Tromans A.,
Thomas D.W.,
Wall M.,
Wallis J.M.,
West A.P.,
Whitehead S.L.,
Willey D.L.,
Williams S.A.,
Wilming L.,
Wray P.W.,
Young L.,
Ashurst J.L.,
Coulson A.,
Blocker H.,
Durbin R.M.,
Sulston J.E.,
Hubbard T.,
Jackson M.J.,
Bentley D.R.,
Beck S.,
Rogers J.,
Dunham I.;
"DNA sequence and analysis of human chromosome 9.";
Nature 429:369-374(2004).
|
[5]
|
NUCLEOTIDE SEQUENCE [MRNA] OF 33-173.
TISSUE=Hematopoietic;
PubMed=7624129 [NCBI, ExPASy, EBI, Israel, Japan]
Duro D.,
Bernard O.,
Della Valle V.,
Berger R.,
Larsen C.J.;
"A new type of p16INK4/MTS1 gene transcript expressed in B-cell malignancies.";
Oncogene 11:21-29(1995).
|
[6]
|
NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 42-173.
Kalnine N.,
Chen X.,
Rolfs A.,
Halleck A.,
Hines L.,
Eisenstein S.,
Koundinya M.,
Raphael J.,
Moreira D.,
Kelley T.,
LaBaer J.,
Lin Y.,
Phelan M.,
Farmer A.;
"Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
|
[7]
|
FUNCTION, AND INTERACTION WITH MDM2.
DOI=10.1093/emboj/17.17.5001; PubMed=9724636 [NCBI, ExPASy, EBI, Israel, Japan]
Stott F.J.,
Bates S.,
James M.C.,
McConnell B.B.,
Starborg M.,
Brookes S.,
Palmero I.,
Ryan K.,
Hara E.,
Vousden K.H.,
Peters G.;
"The alternative product from the human CDKN2A locus, p14(ARF), participates in a regulatory feedback loop with p53 and MDM2.";
EMBO J. 17:5001-5014(1998).
|
[8]
|
FUNCTION, AND INTERACTION WITH TOP1.
DOI=10.1038/sj.onc.1204170; PubMed=11314011 [NCBI, ExPASy, EBI, Israel, Japan]
Karayan L.,
Riou J.-F.,
Seite P.,
Migeon J.,
Cantereau A.,
Larsen C.-J.;
"Human ARF protein interacts with topoisomerase I and stimulates its activity.";
Oncogene 20:836-848(2001).
|
[9]
|
FUNCTION, AND INTERACTION WITH E2F1.
DOI=10.1038/sj.onc.1204220; PubMed=11314038 [NCBI, ExPASy, EBI, Israel, Japan]
Eymin B.,
Karayan L.,
Seite P.,
Brambilla C.,
Brambilla E.,
Larsen C.-J.,
Gazzeri S.;
"Human ARF binds E2F1 and inhibits its transcriptional activity.";
Oncogene 20:1033-1041(2001).
|
[10]
|
INTERACTION WITH CDKN2AIP.
DOI=10.1074/jbc.M204177200; PubMed=12154087 [NCBI, ExPASy, EBI, Israel, Japan]
Hasan M.K.,
Yaguchi T.,
Sugihara T.,
Kumar P.K.R.,
Taira K.,
Reddel R.R.,
Kaul S.C.,
Wadhwa R.;
"CARF is a novel protein that cooperates with mouse p19ARF (human p14ARF) in activating p53.";
J. Biol. Chem. 277:37765-37770(2002).
|
[11]
|
INTERACTION WITH CDKN2AIP.
DOI=10.1016/S0531-5565(02)00180-8; PubMed=12581788 [NCBI, ExPASy, EBI, Israel, Japan]
Wadhwa R.,
Sugihara T.,
Hasan M.K.,
Duncan E.L.,
Taira K.,
Kaul S.C.;
"A novel putative collaborator of p19ARF.";
Exp. Gerontol. 38:245-252(2003).
|
[12]
|
INTERACTION WITH E4F1.
DOI=10.1074/jbc.M210978200; PubMed=12446718 [NCBI, ExPASy, EBI, Israel, Japan]
Rizos H.,
Diefenbach E.,
Badhwar P.,
Woodruff S.,
Becker T.M.,
Rooney R.J.,
Kefford R.F.;
"Association of p14ARF with the p120E4F transcriptional repressor enhances cell cycle inhibition.";
J. Biol. Chem. 278:4981-4989(2003).
|
[13]
|
FUNCTION, AND INTERACTION WITH NPM1.
DOI=10.1016/S1097-2765(03)00431-3; PubMed=14636574 [NCBI, ExPASy, EBI, Israel, Japan]
Itahana K.,
Bhat K.P.,
Jin A.,
Itahana Y.,
Hawke D.,
Kobayashi R.,
Zhang Y.;
"Tumor suppressor ARF degrades B23, a nucleolar protein involved in ribosome biogenesis and cell proliferation.";
Mol. Cell 12:1151-1164(2003).
|
[14]
|
FUNCTION.
DOI=10.1038/sj.onc.1206303; PubMed=12660818 [NCBI, ExPASy, EBI, Israel, Japan]
Eymin B.,
Leduc C.,
Coll J.-L.,
Brambilla E.,
Gazzeri S.;
"p14ARF induces G2 arrest and apoptosis independently of p53 leading to regression of tumours established in nude mice.";
Oncogene 22:1822-1835(2003).
|
[15]
|
FUNCTION, AND INTERACTION WITH TOP1.
DOI=10.1038/sj.onc.1207968; PubMed=15361825 [NCBI, ExPASy, EBI, Israel, Japan]
Ayrault O.,
Andrique L.,
Larsen C.-J.,
Seite P.;
"Human Arf tumor suppressor specifically interacts with chromatin containing the promoter of rRNA genes.";
Oncogene 23:8097-8104(2004).
|
[16]
|
FUNCTION, AND INTERACTION WITH BCL6.
DOI=10.1016/j.bbrc.2004.11.016; PubMed=15567177 [NCBI, ExPASy, EBI, Israel, Japan]
Suzuki H.,
Kurita M.,
Mizumoto K.,
Moriyama M.,
Aiso S.,
Nishimoto I.,
Matsuoka M.;
"The ARF tumor suppressor inhibits BCL6-mediated transcriptional repression.";
Biochem. Biophys. Res. Commun. 326:242-248(2005).
|
[17]
|
FUNCTION, AND INTERACTION WITH HUWE1.
DOI=10.1016/j.cell.2005.03.037; PubMed=15989956 [NCBI, ExPASy, EBI, Israel, Japan]
Chen D.,
Kon N.,
Li M.,
Zhang W.,
Qin J.,
Gu W.;
"ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor.";
Cell 121:1071-1083(2005).
|
[18]
|
FUNCTION, AND INTERACTION WITH UBE2I.
PubMed=15876874 [NCBI, ExPASy, EBI, Israel, Japan]
Rizos H.,
Woodruff S.,
Kefford R.F.;
"p14ARF interacts with the SUMO-conjugating enzyme Ubc9 and promotes the sumoylation of its binding partners.";
Cell Cycle 4:597-603(2005).
|
[19]
|
INTERACTION WITH TBRG1.
DOI=10.1074/jbc.M609612200; PubMed=17110379 [NCBI, ExPASy, EBI, Israel, Japan]
Tompkins V.S.,
Hagen J.,
Frazier A.A.,
Lushnikova T.,
Fitzgerald M.P.,
di Tommaso A.D.,
Ladeveze V.,
Domann F.E.,
Eischen C.M.,
Quelle D.E.;
"A novel nuclear interactor of ARF and MDM2 (NIAM) that maintains chromosomal stability.";
J. Biol. Chem. 282:1322-1333(2007).
|
|
ExPASy Home page
SIB Switzerland